← Open Payments lookup

MEGAN WALSH: Open Payments

NPI 1588137186 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$821 in 37 payments from 12 companies in 2025. Trend: 2023 $921 · 2024 $1,929 · 2025 $821

Food & beverage: $821
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.11$203
ABBVIE INC.6$127
Madrigal Pharmaceuticals4$108
Regeneron Healthcare Solutions, Inc.3$78
GENZYME CORPORATION2$76
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$56
Janssen Biotech, Inc.2$51
Ardelyx, Inc.2$43
Intercept Pharmaceuticals, Inc.1$26
Lilly USA, LLC1$22

Products named: ENTYVIO, DUPIXENT, REZDIFFRA, RINVOQ, XIFAXAN, TREMFYA, CREON, IBSRELA.

Industry payments across MA — which companies pay providers there.